NASDAQ:DNLI | Profit Breakdown | Denali Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$3.6M-$130.54M-$127.55M
2026-03-31-$137.36M-$128.45M
2025-12-31-$137.37M-$128.55M
2025-09-30-$137.43M-$126.9M
2025-06-30$0.00-$134.96M-$124.12M
2025-03-31-$145.58M-$132.97M
2024-12-31$0.00-$129.85M-$114.75M
2024-09-30$0.00-$123.19M-$107.19M
2024-06-30$0.00-$116.59M-$99.03M
2024-03-31$0.00-$117.72M-$101.8M
2023-12-31$0.00-$132.57M-$119.47M
2023-09-30$1.27M-$113.8M-$99.35M
2023-06-30$294.12M$170.48M$183.38M
2023-03-31$35.14M-$120.82M-$109.78M
2022-12-31$10.26M-$105.34M-$98.68M
2022-09-30$184,000.00-$107.49M-$103.3M
2022-06-30$52.48M-$61.42M-$58.79M
2022-03-31$42.14M-$66.5M-$65.22M
2021-12-31$12.51M-$77.12M-$75.26M
2021-09-30$5.29M-$85.59M-$84.59M
2021-06-30$22.94M-$61.82M-$60.69M
2021-03-31$7.92M-$71.22M-$70.04M
2020-12-31$316.81M$244.08M$244.89M
2020-09-30$9.39M-$60.12M-$58.23M
2020-06-30$5.81M-$61.28M-$58.76M
2020-03-31$3.55M-$59.97M-$56.76M
2019-12-31$4.6M-$57.76M-$54.03M
2019-09-30$13.51M-$50.16M-$46.26M
2019-06-30$4.1M-$62.76M-$58.34M
2019-03-31$4.11M-$42.51M-$38.99M
2018-12-31$125.62M$74.72M$77.53M
2018-09-30$1.2M-$37.96M-$35.37M
2018-06-30$1.65M-$57.38M-$54.72M
2018-03-31$641,000.00-$25.75M-$23.68M
2017-12-31$0.00-$23.54M-$22.89M
2017-09-30$0.00-$22.29M-$21.84M
2017-06-30$0.00-$22.57M-$22.13M
2017-03-31-$21.74M-$21.32M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$555.34M-$512.54M
2024-12-31$0.00-$487.34M-$422.77M
2023-12-31$330.53M-$196.7M-$145.22M
2022-12-31$105.07M-$340.74M-$325.99M
2021-12-31$48.66M-$295.75M-$290.58M
2020-12-31$335.56M$62.72M$71.14M
2019-12-31$26.32M-$213.18M-$197.61M
2018-12-31$129.1M-$46.37M-$36.24M
2017-12-31$0.00-$90.14M-$88.19M
2016-12-31$0.00-$87.43M-$86.65M